Intelligent IRT Design Process For COVID-19 Trials Accelerates Digital Enablement At Sites
Source: IQVIA Technologies
![iStock-1271619512-digitization-computer-data iStock-1271619512-digitization-computer-data](https://vertassets.blob.core.windows.net/image/8efb9cf7/8efb9cf7-f0fc-486a-a132-4ab592342d5c/375_250-istock_1271619512_digitization_computer_data.jpg)
Cenduit IRT study design teams took-on the challenges pressing biopharmaceutical industry sponsors as they worked to digitally enable sites and speed time to first-patient-in for COVID-19 therapeutic and vaccine trials.
What resulted included new intelligent design standards that launched seventeen COVID-19 studies rapidly, setting a new bar for accelerating study design by building flexibility into study design standardization.
access the Case Study!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
IQVIA Technologies
This website uses cookies to ensure you get the best experience on our website. Learn more